Category
Atorvastatin
CAS Number
693794-20-6
Alternate CAS Number
693793-53-2(Ca Salt);1807481-00-0(sodium salt)
Molecular Formula
C₃₃H₃₄F₂N₂O₅
Molecular Weight
576.64 g/mol
Catelogue Number
MLS-ATR-RC-C
Synonym

Atorvastatin Calcium Impurity C;(3R,5R)-7-[2,3-bis(4-Fluorophenyl)-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicAcid;(3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-(1-methylethyl)-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicAcid;(3R,5R)-7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic Acid; Atorvastatin EP Impurity C ;

Keywords
Impurities
Impurity Standards
Impurities manufacturer and Suppliers in Hyderabad india
Chiral standards
Intermediates
Pharmaceutical Standards
Aromatics
Fine Chemicals
Slide_1

Atorvastatin Related Compound-C (CAS No: 693794-20-6) is an important intermediate and process-related impurity in the production of atorvastatin calcium, a commonly prescribed cholesterol-lowering medication. It has a molecular formula of C₃₃H₃₄F₂N₂O₅ and a molecular weight of 576.64 g/mol. This compound is carefully monitored in pharmaceutical quality control and is analyzed according to EP (European Pharmacopoeia) and USP (United States Pharmacopeia) standards to ensure the purity, safety, and effectiveness of atorvastatin products. Understanding and controlling Atorvastatin Related Compound-C is vital for impurity profiling, analytical studies, and regulatory compliance, supporting adherence to ICH guidelines as well as FDA and EMA requirements. It is also a key focus in pharmaceutical R&D for optimizing atorvastatin formulations and maintaining high-quality cholesterol-lowering therapies.

Manasa Life Sciences, headquartered in Hyderabad, India, manufactures and supplies high-purity Atorvastatin Related Compound-C to pharmaceutical markets across Asia, Europe, Africa, the GCC, and the UAE. The company ensures full traceability, on-time delivery, and strict compliance with Good Documentation Practices (GDP). As a leading supplier of certified atorvastatin intermediates, Manasa Life Sciences offers comprehensive services including impurity profiling, risk assessment, and method development/validation using HPLC, LC-MS, and other analytical techniques. These solutions enable accurate detection, quantification, and control of atorvastatin impurities, helping manufacturers maintain USP and EP compliance, meet international regulatory standards, and ensure patient safety.